Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. EGFR inhibitors as first-line therapy in advanced non-small cell lung cancer
Your Article Summary
Adding Cetuximab To Chemotherapy Reduces Advanced Lung Cancer Death Risk By 13 Percent
ScienceDaily, 09/22/09
Patients with advanced non–small cell lung cancer who are given cetuximab in addition to chemotherapy are 13% less likely to die than those who receive chemotherapy alone, regardless of which chemotherapy drug cocktail is used, new research finds. They also experience slower disease progression and an increased chance of tumour shrinkage.
Today in Popular Press...keeping you current
Receive free subspecialty "5-minute updates" via email
New technology could boost disease detection tests speed and sensitivity
ScienceDaily, 12/09/09
Quitting smoking can reverse asthma-inducing changes in lungs
ScienceDaily, 12/09/09
Life may be shorter in poorer neighborhoods
Reuters, 12/09/09
Sponsor
Article Search
Sponsor


See Latest Articles


